Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
In 1966, Welborn et al. (1) studied 19 nondiabetic patients with essential hypertension and demonstrated that these individuals had significantly higher plasma insulin concentrations compared with a normotensive control group. Although these observations suggested that the prevalence of resistance to insulin-mediated glucose disposal would be increased in patients with essential hypertension, it wasn’t until approximately 20 yr later that several research groups demonstrated that this was the case (2–7). Although the relationship between insulin resistance, hyperinsulinemia, and essential hypertension has been extensively studied in the past 15 yr, questions continue to be raised as to the nature of the link between these variables. Indeed, there is not even consensus as to whether or not there is a physiological relationship between insulin resistance/compensatory hyperinsulinemia and blood pressure regulation. Another issue, and perhaps of greater clinical relevance, is whether the insulin resistance/compensatory hyperinsulinemia that is frequently present in patients with essential hypertension plays any role in the increased prevalence of cardiovascular disease (CVD) that is the major cause of morbidity and mortality in this clinical syndrome. The goals of this review are to address both of these issues. To begin with, the evidence in support of a role for insulin resistance and compensatory hyperinsulinemia in the pathogenesis of essential hypertension will be summarized…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, hypertension is an insulin-resistant state and PA is frequently associated with hypertension [25,26].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [26]
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
The pathogenesis of atherosclerosis
(1972) · American Heart Journal · doi:10.1016/0002-8703(72)90090-7 · Cited by 1,329
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581 · cited 1×
“Essentially identical findings were observed when the relationship between plasma asymmetric dimethylarginine (ADMA) concentration and insulin-mediated glucose disposal was evaluated (36).”
BackgroundSelf-citationInsulin resistance is a characteristic feature of primary hypertension independent of obesity
Pollare, T., Lithell, H., & Berne, C. (1990) · Metabolism · doi:10.1016/0026-0495(90)90071-j · Cited by 530 · cited 1×
“On the basis of these and other findings (7), approximately 50% of patients with essential hypertension can be considered to be insulin resistant and hyperinsulinemic.”
BackgroundRacial Differences in the Relation between Blood Pressure and Insulin Resistance
Saad, M. F., Lillioja, S., Nyomba, B. L., Castillo, C., Ferraro, R., De Gregorio, M., Ravussin, E., Knowler, W. C., Bennett, P. H., Howard, B. V., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241105 · Cited by 421
Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*
SHEN, D.-C., SHIEH, S.-M., FUH, M. M.-T., WU, D.-A., CHEN, Y.-D. I., & REAVEN, G. M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-3-580 · Cited by 420
Self-citationYeni-Komshian, H., Carantoni, M., Abbasi, F., & Reaven, G. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.171 · Cited by 414 · cited 1×
“Resistance to insulin-mediated glucose disposal and compensatory hyperinsulinemia are continuous variables (25), not dichotomous ones, and there is no simple way to classify a person as being insulin resistant or insulin sensitive.”
BackgroundSelf-citation
Research works printed but not linked: 1
- Reaven, 1993, Treatment of hypertension; focus on prevention of coronary heart disease., J Clin Endocrinol Metab, 76, 537
Cited by
Items 101–200 of 289
Is Low-Risk Hypertension Fact or Fiction?Cardiovascular Risk Profile in the TROPHY Study
NESBITT, S., Julius, S., LEONARD, D., Egan, B. M., & Grozinski, M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.01.021 · Cited by 50
Hypertension, Insulin Resistance, and Aldosterone: Sex‐Specific Relationships
Kidambi, S., Kotchen, J. M., Krishnaswami, S., Grim, C. E., & Kotchen, T. A. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00084.x · Cited by 31
Catena, C., Bernardi, S., Sabato, N., Grillo, A., Ermani, M., Sechi, L. A., Fabris, B., Carretta, R., & Fallo, F. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.05.007 · Cited by 29
“Insulin resistance is also associated with hypertension, and insulin resistance may substantially contribute to the cardiovascular risk in this disorder [5].”
BackgroundAtorvastatin Protects against Ischemia-Reperfusion Injury in Fructose-Induced Insulin Resistant Rats
Prakash, P., Khanna, V., Singh, V., Jyoti, A., Jain, M. K., Keshari, R. S., Barthwal, M. K., & Dikshit, M. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6312-x · Cited by 29
“Sedentary lifestyle also predisposes to IRS leading to type II diabetes mellitus [ 1 ].”
BackgroundFedoseeva, L. A., Klimov, L. O., Ershov, N., Alexandrovich, Y., Efimov, V. M., Markel, А. L., & Redina, O. E. (2016) · BMC Genomics · doi:10.1186/s12864-016-3354-2 · Cited by 29
Karagiannis, A. I., Mikhailidis, D. P., Athyros, V. G., Kakafika, A. I., Τζιόμαλος, Κ., Liberopoulos, E. N., Florentin, M., & Elisaf, M. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.2.191 · Cited by 29
“Insulin resistance is present in ∼ 50% of patients with primary hypertension, but is rarely seen in secondary forms of hypertension [37].”
BackgroundCigarette smoke exposure: A novel cofactor of NAFLD progression?
Mallat, A., & Lotersztajn, S. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.021 · Cited by 28
“Future experiments should therefore investigate the impact of tobacco smoke exposure on these pathways, in particular on fatty acid influx, inasmuch as recent studies indicate that tobacco exposure predisposes to the development of insulin resistance [29,30].”
BackgroundCannizzo, B., Lujan, A. L., Estrella, N., Lembo, C., Cruzado, M., & Castro, C. (2012) · Experimental Diabetes Research · doi:10.1155/2012/941304 · Cited by 28
“There are evidences indicating that structural and functional changes in the vascular wall are involved in cardiovascular alterations associated with MS [3], but the mechanisms underlying are not completely addressed.”
Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet
Diamond, D. M., Bikman, B. T., & Mason, P. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000764 · Cited by 27
Liu, J., Yang, Y., Zhou, J., Liu, T., Zhang, W., Wei, L., & Wu, S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197341 · Cited by 26
“We found better compliance behaviors in overweight and obese individuals than those with normal weight, which is in line with Reaven’s [46] finding.”
ResultNardo, F. D., Burattini, R., Cogo, C. E., Faelli, E. L., & Ruggeri, P. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2008.044529 · Cited by 26
“Email: r.burattini@univpm.it The association of obesity, insulin resistance and cardiovascular dysfunction is well recognized in humans (Ferrannini & De Fronzo, 1989; Reaven, 2003).”
BackgroundInfluentialFibrates for treatment of the metabolic syndrome
Maki, K. C. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0115-5 · Cited by 24
“The interested reader is referred to reviews by Reaven [ 8 ] and Lopez-Candales [9] for greater detail.”
MethodSteinhardt, A. P., Tellechea, M. L., Rosso, L. A. G., Brites, F. D., Frechtel, G. D., & Poskus, E. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-166 · Cited by 24
“The metabolic syndrome (MS) is a constellation of cardiometabolic risk factors including central obesity, insulin resistance (IR), hypertension, hyperglycemia, and dislipidemia [1,2].”
BackgroundAbuissa, H. S., & O’Keefe, J. H. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00898.x · Cited by 23
Parker, J., O'Brien, C. L., Yeoh, C., Gersh, F. L., & Brennecke, S. P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061774 · Cited by 23
“Hyperinsulinemia can disrupt the usual physiological balance of the RAAS by influencing the activity of regulatory enzymes, receptors, and effector proteins [152,182].”
BackgroundMendez, C. E., Walker, R. J., Eiler, C., Mishriky, B. M., & Egede, L. E. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1643635 · Cited by 22
“dent factor or as part of the metabolic syndrome [15,16].”
BackgroundLipoprotein (a) levels in relation to severity of coronary artery disease in north Indian patients
Ashfaq, F., Goel, P. K., Sethi, R., Khan, M., Ali, W., & Idris, M. Z. (2013) · Heart Views · doi:10.4103/1995-705x.107114 · Cited by 24
“[15] Triglyceride concentrations (130 mg/dl) had a positive predictive value of 70% to identify individuals at risk for insulin resistance[16] and insulin resistance and hypertriglyceridemia may contribute together to the increased risk of CAD in hypertension.[17] Relation between Lp (a) and coronary disease should be…”
He, Z., Zhihong, S. U. N., Shimin, L. I. U., Zhang, Q., & Tan, Z. (2009) · Journal of Veterinary Medical Science · doi:10.1292/jvms.71.1143 · Cited by 22
“The resultant hyperglycemia stimulates beta cells, which secrete large amounts of insulin after meals [71].”
BackgroundInsulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism
Grewal, S., Fosam, A., Chalk, L., Deven, A., Suzuki, M., Correa, R. R., Blau, J. E., Demidowich, A. P., Stratakis, C. A., & Muniyappa, R. (2021) · Endocrine · doi:10.1007/s12020-020-02576-y · Cited by 20
“First, hypertension is an insulin-resistant state, and PA is frequently associated with hypertension [25, 26].”
BackgroundMetabolic and Respiratory Comorbidities of Childhood Obesity
Fennoy, I. (2010) · Pediatric Annals · doi:10.3928/00904481-20100223-08 · Cited by 28
Rao, M. N., Chau, A., Madden, E., Inslicht, S. S., Talbot, L. S., Richards, A. L., O’Donovan, A., Yack, L. M., Grünfeld, C., & Neylan, T. C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.006 · Cited by 20
“Insulin resistance is a key step in the development of DM nd is associated with a variety of adverse health outcomes Reaven, 1995, 2003).”
BackgroundSo What Comes First: The Obesity or the Insulin Resistance? And Which Is More Important?
Noakes, T. D. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.282962 · Cited by 24
Afifi, S. M., Ammar, N. M., Kamel, R., Esatbeyoglu, T., & Hassan, H. A. (2022) · Antioxidants · doi:10.3390/antiox11051023 · Cited by 20
“Insulin resistance is a condition in blunted response to insulin stimulation of target tissues [6], and it manifests as hyperglycemia and compensative hyper-insulinemia [7].”
BackgroundEsteghamati, A., Khalilzadeh, O., Abbasi, M., Nakhjavani, M., Novin, L., & Esteghamati, A. R. (2008) · Clinical and Experimental Hypertension · doi:10.1080/10641960802269919 · Cited by 22
Diabetic Peripheral Neuropathy Associated with Foot Ulcer: One of a Kind
Sen, C. K., Roy, S., & Khanna, S. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0093 · Cited by 19
Consenso latinoamericano de hipertensión en pacientes con diabetes tipo 2 y síndrome metabólico
López-Jaramillo, P. A., Sanchez, R. A., Díaz, M., Cobos, L., Bryce, A., Parra-Carrillo, J. Z., Lizcano, F., Lanas, F. T., Sinay, I. R., Sierra, I. D., et al. (2013) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2013.11.008 · Cited by 29
“Actualmente esta bien aceptado que todos los componentes del síndrome metabólico están asociadas con resistencia a la insulina (26,62,63).”
BackgroundLee, C. J., Lim, N.-K., Kim, H. C., Ihm, S., Lee, H., Park, H., & Park, S. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu186 · Cited by 19
Chopra, A. K. (2020) · Indian Journal of Clinical Cardiology · doi:10.1177/2632463620935030 · Cited by 25
Amin, A. M. (2021) · Lifestyle Medicine · doi:10.1002/lim2.25 · Cited by 21
Noakes, T. D. (2021) · Open Heart · doi:10.1136/openhrt-2021-001680 · Cited by 19
Relationship among age, insulin resistance, and blood pressure
Jung, C., Jung, S. H., Lee, B., Rosenberg, M., Reaven, G. M., & Kim, S. H. (2017) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2017.04.005 · Cited by 18
Self-citationMetabolic Effects of Manidipine
Cavalieri, L., & Cremonesi, G. (2009) · American Journal of Cardiovascular Drugs · doi:10.1007/bf03256573 · Cited by 19
Fazio, S., Mercurio, V., Fazio, V., Ruvolo, A., & Affuso, F. (2024) · Biomedicines · doi:10.3390/biomedicines12040806 · Cited by 17
“It is well known that IR is a key mechanism in the pathogenesis of type 2 diabetes but also of systemic arterial hypertension, atherosclerosis, and, in particular, HFpEF, as well as other various atherosclerotic and non-atherosclerotic cardiovascular diseases [21–23].”
BackgroundDevarajan, N., Rajendran, K., Shirin, V., Manohar, G., & Malathi, R. (2015) · Thrombosis Journal · doi:10.1186/s12959-015-0042-4 · Cited by 17
“Insulin resistance as well as compensatory hyperinsulinemia associated with insulin resistance is shown to be independent predictors for CVD [33].”
BackgroundDziwura, J., Bińczak‐Kuleta, A., Miazgowski, T., Ziemak, J., & Widecka, K. (2011) · Hypertension Research · doi:10.1038/hr.2011.80 · Cited by 17
Síndrome Metabólica, seus fenótipos e resistência à insulina pelo HOMA-RI
de Oliveira, E. P., de Lima, M. D. D. A., & de Souza, M. L. A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000900014 · Cited by 23
Correlation of the Dysmetabolic Risk Factors with Different Anthropometric Measurements
Chiou, W., Lin, J., Weng, H., Yung-Chun, O. U., Liu, T.-H., & Fang, J. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.139 · Cited by 17
Rhodes, E. T., Prosser, L. A., Lieu, T. A., Songer, T. J., Ludwig, D. S., & Laffel, L. M. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00772.x · Cited by 17
Ward, N. C., Hodgson, J. M., Puddey, I. B., Beilin, L. J., & Croft, K. D. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.04.001 · Cited by 16
Ashfaq, F., Goel, P. K., Moorthy, N., Sethi, R., Khan, M. I., & Idris, M. Z. (2012) · Sultan Qaboos University medical journal · doi:10.12816/0003172 · Cited by 16
Lower hypertension risk in Mexico City than in San Antonio
LORENZO, C., Williams, K., Gonzalez-Villalpando, C., Stern, M. P., Hazuda, H. P., & Haffner, S. M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.10.022 · Cited by 16
Zhu, B. T. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022012 · Cited by 17
“For example, exposure of certain brain regions to elevated insulin levels results in increased sympathetic discharge, usually manifesting in the form of elevated blood pressure [452,453].”
BackgroundBurattini, R., Nardo, F. D., Casagrande, F., Boemi, M., & Morosini, P. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.010 · Cited by 15
“Furthermore, statistical technique of factor analysis, often used to evaluate the role of hypertension among a cluster of abnormalities that associate with insulin resistance and/or hyperinsulinemia, yields conclusions that are likely to be affected by etiologic and clinical heterogeneity of patients with essential hy…”
BackgroundMethodResultInfluentialQureshi, K., & Abrams, G. A. (2016) · Clinical Obesity · doi:10.1111/cob.12132 · Cited by 15
“NAFLD, DM or cardiovascular disease (26).”
Lin, M., Hwu, C. M., Huang, Y. H., Sheu, W. H., Shih, K., Chiang, F., Olshen, R. A., Chen, Y. I., Curb, J. D., Rodríguez, B. L., et al. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.04.003 · Cited by 15
Grundy, S. M. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_3 · Cited by 17
Clément, K., Stunff, C. L., Meirhaeghe, A., Dechartres, A., Ferrières, J., Basdevant, A., Boîtard, C., Amouyel, P., & Bougneres, P. F. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.11.160 · Cited by 14
Dietary Patterns, Smoking, and Cardiovascular Diseases: A Complex Association
Kimokoti, R. W., & Newby, P. K. (2013) · Current Nutrition Reports · doi:10.1007/s13668-013-0043-5 · Cited by 14
“Smoking likewise causes hypertension through the sympathomimetic effects of nicotine [21, 61–63].”
BackgroundDietary patterns and C-peptide concentrations in a Japanese working population
Akter, S., Nanri, A., Yi, S., Pham, N. M., Kurotani, K., Kimura, Y., Matsushita, Y., & Mizoue, T. (2012) · Nutrition · doi:10.1016/j.nut.2012.01.018 · Cited by 14
“Insulin resistance is an important underlying condition of type 2 diabetes and a predictor of many chronic diseases [8,9].”
BackgroundGalgani, J. E., de Jonge, L., Rood, J. C., Smith, S. R., Young, A. A., & Ravussin, É. (2010) · Obesity · doi:10.1038/oby.2010.70 · Cited by 15
“It is widely acknowledged that insulin resistance, independent of obesity, predicts the development of type 2 diabetes mellitus, and cardiovascular disease (1).”
BackgroundManabe, S., Okura, T., Fukuoka, T., & Higaki, J. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.022 · Cited by 14
VISCERAL ADIPOSITY INDEX (VAI) – A POTENTIAL MARKER OF CARDIOMETABOLIC RISK
GÂRGAVU, S. R., Clenciu, D., ROȘU, M. M., Cojan, T. Ș. Ț., Costache, A. C., Vladu, I. M., & MOȚA, M. (2018) · Archives of the Balkan Medical Union · doi:10.31688/abmu.2018.53.2.11 · Cited by 13
The metabolic syndrome: A vascular perspective
Tamsma, J. T., Jazet, I. M., Beishuizen, E. D., Fogteloo, A. J., Meinders, A. E., & Huisman, M. V. (2005) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.01.011 · Cited by 16
Mir, F. A., Mall, R., Ullah, E., Iskandarani, A., Cyprian, F. S., Samra, T. A., Alkasem, M., Abdalhakam, I., Farooq, F., Taheri, S., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04074-x · Cited by 14
“Elevated insulin secretion reflects increased insulin resistance that is observed in the OBM group [42, 43].”
BackgroundEffects of coenzyme Q10 and ^|^alpha;-lipoic acid supplementation in fructose fed rats
zdogan, S. O., Kaman, D., & Simsek, B. U. C. O. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-47 · Cited by 12
RetractedWare, W. R. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.02.008 · Cited by 12
“In addition, in ATP III attention is directed to triglyceride levels only as regards the question of the metabolic syndrome in spite of its relevance in connection with that aspect of dyslipidemia (high triglycerides (TG), low HDL) associated not only with insulin resistance but also with the risk in general of CHD [4…”
BackgroundInsulin Resistance and the Metabolic Syndrome
Banerji, M. A., & Chaiken, R. L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_34 · Cited by 12
Prevalence of Metabolic Syndrome among Filipino-Americans: A Cross-Sectional Study
Angosta, A. D., & Gutierrez, A. P. (2013) · Applied Nursing Research · doi:10.1016/j.apnr.2013.06.005 · Cited by 12
“Central adiposity has been linked to the development of T2D and to the syndrome itself (Grundy et al., 2005; Reaven, 2003).”
BackgroundNardo, F. D., Boemi, M., & Burattini, R. (2009) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2009.08.007 · Cited by 11
[Consensus on Systemic Arterial Hypertension In México].
Rosas-Peralta, M., Palomo‐Piñón, S., Borrayo–Sánchez, G., Madrid-Miller, A., Almeida‐Gutiérrez, E., Galván‐Oseguera, H., Magaña‐Serrano, J. A., Saturno-Chiu, G., Ramírez-Árias, E., Santos-Martínez, E., et al. (2016) · PubMed · Cited by 11
Hosseinzadeh‐Attar, M. J., Hajianfar, H., & Bahonar, A. (2012) · PubMed Central · Cited by 11
Matayoshi, T., Kamide, K., Takiuchi, S., Horio, T., Yoshihara, F., Nakamura, S., Nakahama, H., & Kawano, Y. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960701616186 · Cited by 11
Plasma Adiponectin and Insulin Resistance in New Onset Hypertension
Doğru, T., Sönmez, A., Taşçı, İ., Yılmaz, M. İ., Kılıç, S., Özgürtaş, T., Eyileten, T., Erbil, M. K., & Kocar, I. H. (2006) · Endocrine · doi:10.1385/endo:29:3:405 · Cited by 11
Hwu, C., Hsiung, C. A., Wu, K., Lee, W.-J., Shih, K., Grove, J., Chen, Y. I., Rodríguez, B. L., Curb, J. D., & The SAPPHIRe Study Group (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01818.x · Cited by 11
Burattini, R., Morettini, M., Nardo, F. D., & Boemi, M. (2011) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-011-0760-0 · Cited by 10
“Circulating insulin concentration depends upon b-cell insulin secretion through insulin distribution and clearance, with hepatic degradation playing a major role [1, 5, 14, 17, 22, 25, 30].”
BackgroundA new antihypertensive drug ameliorate insulin resistance
Liu, Y. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.31 · Cited by 10
Manidipine: A different dihydropyridine
Rizos, C. V. (2011) · World Journal of Hypertension · doi:10.5494/wjh.v1.i1.3 · Cited by 11
Non-Dipping and Cardiometabolic Profile: A Study on Normotensive Overweight Middle-Aged Men
Albert, B. B., de Bock, M. I., Derraik, J. G. B., Brennan, C. M., Biggs, J. B., Hofman, P. L., & Cutfield, W. S. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.04.012 · Cited by 10
“insulin sensitivity (insulin resistance) with hyperinsulinaemia [25–27].”
BackgroundRole of hypertension in the metabolic syndrome: Who is affected?
Velarde, G., & Berk, B. C. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0036-x · Cited by 10
High triglyceride level is associated with severe coronary artery disease in hypertensive subjects
Chen, C., Hwu, C., Lin, M., Tsai, C.-H., & Yeh, H. (2008) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430701840325 · Cited by 9
“Insulin resistance and hypertriglyceridemia may contribute together to the increased risk of CAD in hypertension (3,14).”
BackgroundMeasurements of insulin resistance in hypertension: where are we now?
Cm, H. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002202 · Cited by 9
Effect of Phyllanthus fraternus on Fructose Induced Insulin Resistance in Rats
Kushwah, A. S., Patil, B. M., & Thippeswam, B. S. (2010) · International Journal of Pharmacology · doi:10.3923/ijp.2010.624.630 · Cited by 10
Zhao, G., Shang, S., Tian, N., Zhan, X., Peng, F., Wang, X., Wen, Y., Xu, Q., Feng, X., Tang, X., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02275-x · Cited by 8
Zhou, M., Wang, S., Jing, J., Yang, Y., Cai, X., Meng, X., Mei, L., Lin, J., Li, S., Li, H., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002897 · Cited by 7
Hephzibah, K., & Shanmugasundaram, S. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e95099 · Cited by 7
The role of acute hyperinsulinemia in the development of cardiac arrhythmias
Drimba, L., Döbrönte, R., Hegedűs, C., Sári, R. Z., Di, Y., Németh, J., Szilvássy, Z., & Peitl, B. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0845-4 · Cited by 7
“Patients with impaired metabolic control have greater propensity to develop frequent appearance of cardiac arrhythmias (Reaven 2003; Adabag et al. 2010), although the precise mechanisms leading to cardiac rhythm disturbances are not fully understood.”
BackgroundTranslational Vascular Medicine: Pathogenesis, Diagnosis, and Treatment
Abraham, D., Handler, C., Dashwood, M. R., & Coghlan, G. (2011) · Springer eBooks · doi:10.1007/978-0-85729-920-8 · Cited by 7
Ruderman, N. B., & Shulman, G. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00043-3 · Cited by 24
Grundy, S. M. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_3 · Cited by 7
Surrogate estimates of insulin sensitivity in subjects with hypertension
Hwu, C., Hsiao, C., Grove, J., Hung, Y., Chuang, L., Chen, Y. T., Curb, J. D., Chen, Y. I., Rodríguez, B. L., Ho, L. ‐., et al. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002137 · Cited by 7
Ruderman, N. B., & Shulman, G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00044-7 · Cited by 9
Squillace, N., Lapadula, G., Torti, C., Orlando, G., Mandalia, S., Nardini, G., Beghetto, B., Costarelli, S., & Guaraldi, G. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00539.x · Cited by 8
Pathophysiology and Management of Dyslipidemias Associated with Insulin-Resistant States
Maki, K. C., Benes, L. B., & Dicklin, M. R. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_16 · Cited by 8
Factores de riesgo cardiovascular dependientes del paciente en población con infección por VIH
Portilla, J. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(09)73440-8 · Cited by 6
Pinkston, M. M., Poston, W. S. C., Reeves, R. S., Haddock, C. K., Taylor, J. E., & Foreyt, J. P. (2006) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03327751 · Cited by 7
Ware, W. R. (2010) · Cited by 6
Understanding insulin resistance: What are the clinical implications?
Sivitz, W. I. (2004) · Postgraduate Medicine · doi:10.3810/pgm.2004.07.1550 · Cited by 9
Kamani, L., Siddiqui, M., & Rahat, A. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03790-6 · Cited by 5
“…resulting in increased levels of triglycerides, free fatty acids and synthesis of dyslipidemic particles, which consequently increase the risk of Cardiovascular disease (CVD) [14, 15] and excessive accumulation of lipid in pancreas impairs secretion, further exacerbating metabolic dysfunction [16].”
Central insulin–angiotensin II interaction in blood pressure regulation in fructose overloaded rats
Mayer, M. A., Höcht, C., Giani, J., Muñoz, M. C., Carranza, A., Taira, C. A., Dominici, F. P., Puyó, A. M., & Fernández, B. E. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.06.001 · Cited by 5
“There is a large body of experimental evidence showing that insulin resistance and compensatory hyperinsulinemia play a role in the development of hypertension in the metabolic syndrome [1].”
Mishriky, B. M., Cummings, D. M., Tanenberg, R. J., & Pories, W. J. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1533381 · Cited by 6
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., Lam, M. L., & Chaiken, R. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_34-2 · Cited by 5
Oyama, N., Urasawa, K., Sakai, H., Fujii, S., & Kitabatake, A. (2005) · Heart and Vessels · doi:10.1007/s00380-004-0784-6 · Cited by 5
“In addition, insulin resistance and/or compensatory hyperinsulinemia have also been shown in several large, prospective, population-based studies to predict the development of essential hypertension.(18) In a previous study, patients with microvascular angina showed a hyperglycemic and hyperinsulinemic response to ora…”
ResultSíndrome metabólico. Aspectos fisiopatológicos e importancia epidemiológica
Chávez-Tapia, N. C., Valdés, P. A., Kuba, D., Sánchez, K. S., & Méndez‐Sánchez, N. (2004) · Médica Sur · Cited by 13
Role of Aldosterone in Insulin Resistance: Fact of Fantasy
Sechi, L. A., & Colussi, G. (2015) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000161 · Cited by 4
“The issue of a possible relationship between plasma aldosterone and insulin resistance is important because aldosterone has been shown to contribute, independent of blood pressure, to the development of cardiovascular damage [26] and because insulin resistance and hyperinsulinemia are predictors of cardiovascular even…”
BackgroundSalazar, M. R., Carbajal, H. A., Espeche, W. G., Balbín, E., Aizpurúa, M., Marillet, A. G., & Reaven, G. M. (2014) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.869982 · Cited by 4
“This finding was surprising, because patients with essential hypertension, as a group, are insulin resistant and hyperinsulinemic; normotensive first-degree relatives of patients with essential hypertension are relatively insulin resistant and hyperinsulinemic; and surrogate estimates of insulin resistance in prospect…”
BackgroundSelf-citationKaku, K., Enya, K., Sugiura, K., & Totsuka, N. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.630386 · Cited by 4
Insulin Resistance: Regression and Clustering
Yoon, S., Assimes, T. L., Quertermous, T., Hsiao, C., Chuang, L., Hwu, C., Rajaratnam, B., & Olshen, R. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094129 · Cited by 6
“IR/compensatory hyperinsulinemia also appears to contribute to the complex pathogenesis of the most common form of elevated blood pressure, namely essential hypertension [2],[3] by promoting water resorption in the kidney and/or increased activity of the sympathetic nervous system.”
BackgroundFuzai, Y., Lü, Q., Shuyi, W., Ma, C., Lou, D., Liu, B., & Liu, X. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.146 · Cited by 4
Significant association of insulin and proinsulin with clustering of cardiovascular risk factors
Jia, E. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i1.149 · Cited by 4
Level of proinsulin in association with cardiovascular risk factors and sleep snoring
Jia, E. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i32.5047 · Cited by 4
Metadata
- Authors
- Reaven, G. M.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Reaven, Gerald M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 88
- Issue
- 6
- Pages
- 2399-2403
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2033704972
- Semantic Scholar
- 273ddc01929a0f425076be991fd96bb78d531c52
- Cited by
- 284
- References
- 43
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 4 · 2018: 7 · 2017: 12 · 2016: 8 · 2015: 7 · 2014: 10 · 2013: 17 · 2012: 14
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- insulin resistance, compensatory hyperinsulinemia, essential hypertension, cardiovascular disease, blood pressure regulation, insulin-stimulated glucose disposal, fasting insulin
- MeSH terms
- Adaptation, Physiological, Cardiovascular Diseases, Humans, Hyperinsulinism, Hypertension, Insulin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.